Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Clinical trial NCT06676319 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06676319
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2027-06-21
- Enrollment
- 556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.